(Q38150488)

29 August 2017

title

Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: comparison with schizophrenia (English)

1 reference

29 August 2017

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24102953%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

A Carlo Altamura

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24102953%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Sara Pozzoli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24102953%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

1 reference

19 September 2013

1 reference

Psychiatry and Clinical Neurosciences

29 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24102953%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24102953%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24102953%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

21-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24102953%20AND%20SRC:MED&resulttype=core&format=json

A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder

1 June 2020

cites work

1 reference

Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology

21 January 2018

1 reference

Cytokines and the brain: implications for clinical psychiatry

21 January 2018

1 reference

Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.

21 January 2018

1 reference

Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition

21 January 2018

1 reference

Interferon-alpha, cytokines and possible implications for mood disorders.

21 January 2018

1 reference

Interleukin-1 immunoreactive innervation of the human hypothalamus

21 January 2018

1 reference

Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system

21 January 2018

1 reference

Cytokines and major depression

21 January 2018

1 reference

The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system

21 January 2018

1 reference

Cytokines, stress, and depressive illness

21 January 2018

1 reference

Cytokines and myelination in the central nervous system.

21 January 2018

1 reference

Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.

21 January 2018

1 reference

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia

21 January 2018

1 reference

The association of infectious agents and schizophrenia

21 January 2018

1 reference

Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis

21 January 2018

1 reference

Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?

21 January 2018

1 reference

Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia

21 January 2018

1 reference

Neonatal antibodies to infectious agents and risk of bipolar disorder: a population-based case-control study

21 January 2018

1 reference

The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey

21 January 2018

1 reference

Adult major affective disorder after prenatal exposure to an influenza epidemic.

21 January 2018

1 reference

Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level

21 January 2018

1 reference

Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?

21 January 2018

1 reference

Minocycline: therapeutic potential in psychiatry

21 January 2018

1 reference

Serum and gene expression profile of cytokines in first-episode psychosis

21 January 2018

1 reference

The neurodevelopmental hypothesis of schizophrenia: a review of recent developments.

21 January 2018

1 reference

Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease--there is no schizoaffective disorder

21 January 2018

1 reference

Neuroprogression in bipolar disorder

21 January 2018

1 reference

Cytokines and CNS development

21 January 2018

1 reference

Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia.

21 January 2018

1 reference

Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn

21 January 2018

1 reference

Prenatal infection and schizophrenia: a review of epidemiologic and translational studies

21 January 2018

1 reference

The effects of maternal inflammation on neuronal development: possible mechanisms

21 January 2018

1 reference

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia.

21 January 2018

1 reference

Immune involvement in schizophrenia and autism: etiology, pathology and animal models

21 January 2018

1 reference

HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment

21 January 2018

1 reference

White matter changes in schizophrenia: evidence for myelin-related dysfunction

21 January 2018

1 reference

Cytokine production in chorioamnionitis

21 January 2018

1 reference

Stress, depression, and the role of cytokines

21 January 2018

1 reference

Dynamic regulation of proinflammatory cytokines

21 January 2018

1 reference

The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety.

21 January 2018

1 reference

Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways

21 January 2018

1 reference

Acute stress effects on local Il-1beta responses to pathogens in a human in vivo model

21 January 2018

1 reference

Prenatal origins of individual variation in behavior and immunity

21 January 2018

1 reference

Prenatal stress, fetal imprinting and immunity

21 January 2018

1 reference

White matter neuron alterations in schizophrenia and related disorders

21 January 2018

1 reference

Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients.

21 January 2018

1 reference

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission

21 January 2018

1 reference

Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects

21 January 2018

1 reference

Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.

21 January 2018

1 reference

3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia

21 January 2018

1 reference

Immune abnormalities in schizophrenia: evidence for the autoimmune hypothesis

21 January 2018

1 reference

Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia

21 January 2018

1 reference

Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature

21 January 2018

1 reference

The role of immune function in schizophrenia: an overview

21 January 2018

1 reference

MCP-1 gene (SCYA2) and schizophrenia: a case-control association study.

21 January 2018

1 reference

Epidemiology of schizophrenia: the global burden of disease and disability

21 January 2018

1 reference

Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers

21 January 2018

1 reference

An autoimmune or an inflammatory process in patients with schizophrenia, schizoaffective disorder, and in their biological relatives

21 January 2018

1 reference

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

21 January 2018

1 reference

Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models

21 January 2018

1 reference

The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence

21 January 2018

1 reference

The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder

21 January 2018

1 reference

Th1, Th2 and Th3 cytokine alteration in schizophrenia

21 January 2018

1 reference

Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation

21 January 2018

1 reference

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

21 January 2018

1 reference

Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls

21 January 2018

1 reference

Monocyte chemoattractant protein-1 in schizophrenia: -2518A/G genetic variant and protein levels in Armenian population.

21 January 2018

1 reference

Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity

21 January 2018

1 reference

A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia

21 January 2018

1 reference

Membrane phospholipids and cytokine interaction in schizophrenia

21 January 2018

1 reference

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

21 January 2018

1 reference

Evidence for a role of the arachidonic acid cascade in affective disorders: a review

21 January 2018

1 reference

Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia

21 January 2018

1 reference

Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view

21 January 2018

1 reference

Decreased plasma antioxidants in schizophrenia

21 January 2018

1 reference

Reduced level of plasma antioxidant uric acid in schizophrenia.

21 January 2018

1 reference

Vitamin C status in chronic schizophrenia

21 January 2018

1 reference

Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients.

21 January 2018

1 reference

Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia.

21 January 2018

1 reference

Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia

21 January 2018

1 reference

Schizophrenia: metabolic aspects of aetiology, diagnosis and future treatment strategies

21 January 2018

1 reference

Inter-relationship of plasma markers of oxidative stress and thyroid hormones in schizophrenics

21 January 2018

1 reference

The macrophage theory of depression

21 January 2018

1 reference

Peripheral biomarkers and illness activity in bipolar disorder

21 January 2018

1 reference

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

21 January 2018

1 reference

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

21 January 2018

1 reference

Immune activation, steroid resistancy and bipolar disorder.

21 January 2018

1 reference

Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder

21 January 2018

1 reference

Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population.

21 January 2018

1 reference

A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.

21 January 2018

1 reference

The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study

21 January 2018

1 reference

Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study

21 January 2018

1 reference

Linkage and linkage disequilibrium of evoked EEG oscillations with CHRM2 receptor gene polymorphisms: implications for human brain dynamics and cognition

21 January 2018

1 reference

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence

21 January 2018

1 reference

Tryptophan breakdown pathway in bipolar mania

21 January 2018

1 reference

Impact of IL-1 receptor antagonist gene polymorphism on schizophrenia and bipolar disorder

21 January 2018

1 reference

Chemokines in bipolar disorder: trait or state?

21 January 2018

1 reference

Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder

21 January 2018

1 reference

Brain lipid concentrations in bipolar disorder

21 January 2018

1 reference

Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder

21 January 2018

1 reference

Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients

21 January 2018

1 reference

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness

21 January 2018

1 reference

Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable mood

21 January 2018

1 reference

Prominent clinical dimension, duration of illness and treatment response in schizophrenia: a naturalistic study

21 January 2018

1 reference

Leukocyte elastase and autoantibodies to nerve growth factor in the acute phase of schizophrenia and their relationship to symptomatology.

21 January 2018

1 reference

Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia

21 January 2018

1 reference

Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.

21 January 2018

1 reference

Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.

21 January 2018

1 reference

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide

21 January 2018

1 reference

Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorder

21 January 2018

1 reference

Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder

21 January 2018

1 reference

Serological observations in patients suffering from acute manic episodes

21 January 2018

1 reference

Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia

21 January 2018

1 reference

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

21 January 2018

1 reference

Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6.

21 January 2018

1 reference

Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor

21 January 2018

1 reference

Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders

21 January 2018

1 reference

Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment

21 January 2018

1 reference

Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder.

21 January 2018

1 reference

Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample

21 January 2018

1 reference

Immune variations in bipolar disorder: phasic differences

21 January 2018

1 reference